Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosisClaire E Walters, Gareth Pryce, Deborah J R Hankey, et al.
Communications Biology|November 6, 2025
O-glycosylated peptides curtail the aggregation and toxicity of human islet amyloid polypeptideQian Zhang, Xiaohan Mei, Yan Li, et al.
Angewandte Chemie (International Ed. in English)|February 21, 2014
Diphenylacetylene-linked peptide strands induce bidirectional β-sheet formationHannah Lingard, Jeongmin T Han, Amber L Thompson, et al.
Nature Materials|May 3, 2016
Tuning hardness in calcite by incorporation of amino acidsYi-Yeoun Kim, Joseph D Carloni, Beatrice Demarchi, et al.
Molecular Cancer Therapeutics|March 18, 2004
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activityJames Turkson, Joon S Kim, Shumin Zhang, et al.
The Journal of Biological Chemistry|February 13, 2002
Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cellsXianwu Li, Li Liu, Joan C Tupper, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseJuliana Ruiz-Caro, Aravind Basavapathruni, Joseph T Kim, et al.
Cancer Letters|December 27, 2005
Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cellsAikaterini Anagnostopoulou, Adina Vultur, Rozanne Arulanandam, et al.
Oncogene|September 19, 2003
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/ArfZhongqiu Zhang, Yian Wang, Laura E Lantry, et al.
Molecular and Cellular Biology|September 19, 2007
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growthSamuel C Falsetti, De-an Wang, Hairuo Peng, et al.
Pageof 22